Ani Pharmaceuticals Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.26M2.47M0.44M20.37M30.08M55.97M76.32M128.62M176.84M201.58M206.55M208.47M216.14M316.38M486.82M614.38M
Cost of Revenue 9.17M9.97M11.47M12.69M48.78M79.03M73.02M63.15M87.16M100.61M138.78M181.51M250.21M
Gross Profit 11.20M20.11M44.50M63.63M79.84M97.81M128.55M143.39M121.32M115.53M177.60M305.30M364.17M
Operating items
Depreciation & Amortization - Total 0.52M0.50M0.60M0.70M0.90M1.20M2.10M4.40M4.80M5.50M7.40M7.50M7.40M
Research & Development 13.68M39.71M44.18M1.16M1.71M2.68M2.87M2.91M9.07M15.40M19.81M16.00M11.37M22.32M34.29M44.58M
Selling, General & Administrative 5.37M5.94M6.98M9.52M16.39M17.93M21.16M27.83M31.58M44.06M55.84M64.99M84.29M124.04M161.70M249.64M
Restructuring Costs 5.68M1.13M
Other Operating Expenses 29.63M0.44M0.20M9.22M10.58M14.75M18.89M76.91M106.66M104.65M110.15M-48.81M-8.75M192.23M235.23M312.18M
Operating Expenses 48.68M46.08M51.36M20.41M29.18M35.96M43.62M108.54M148.51M166.22M190.20M224.49M255.93M351.67M439.85M613.79M
Operating Income -15.94M-17.80M-0.04M0.90M20.01M32.70M20.08M28.33M35.36M16.35M-16.02M-39.79M-35.28M46.97M0.58M
EBIT -15.94M-17.80M-0.04M0.90M20.01M32.70M20.08M28.33M35.36M16.35M-16.02M-39.79M-35.28M46.97M0.58M
Non-operating items
Interest & Investment Income 0.01M0.01M0.01M-0.47M-0.79M-11.01M-11.33M-12.04M-14.76M-12.97M-9.45M-11.92M-28.05M-26.94M-17.60M
Other Non Operating Income -1.87M-0.02M-0.24M-0.30M0.16M0.04M-0.07M0.06M-0.55M-0.23M-0.49M-4.34M0.67M-0.16M-7.47M
Non Operating Income -0.24M-0.30M0.16M0.04M-0.07M0.06M-0.55M-0.23M-0.49M-4.34M0.67M-0.16M-4.03M
Net income details
EBT -46.20M-51.61M-1.61M0.13M19.38M21.73M8.68M16.35M20.05M3.16M-25.96M-56.06M-62.66M19.87M-22.21M
Tax Provisions -0.04M0.02M-9.37M6.36M4.74M17.43M9.74M6.20M9.79M-13.46M-14.77M1.09M-3.69M
Profit After Tax 47.53M-46.20M-51.61M-1.57M0.30M28.75M15.38M3.93M-1.08M15.49M6.09M-22.55M-42.60M-47.90M18.78M-18.52M
Equity Income 6.31M
Income from Continuing Operations -46.20M-51.61M-1.57M0.11M28.75M15.38M3.93M-1.08M10.31M-3.04M-35.75M-42.60M-47.90M18.78M-18.52M
Consolidated Net Income -46.20M-51.61M-1.57M0.11M28.75M15.38M3.93M-1.08M10.31M-3.04M-35.75M-42.60M-47.90M18.78M-18.52M
Income towards Parent Company -46.20M-51.61M-1.57M0.11M28.75M15.38M3.93M-1.08M10.31M-3.04M-35.75M-42.60M-47.90M18.78M-18.52M
Preferred Dividend Payments 6.92M4.97M0.19M1.62M1.62M1.62M
Net Income towards Common Stockholders -47.53M-46.20M-51.61M-8.50M-4.87M28.75M15.38M3.93M-1.08M10.31M6.09M-22.55M-42.79M-49.52M17.15M-20.15M
Additional items
EPS (Basic) -1.40-4.21-3.15-2.08-0.962.611.340.34-0.091.310.51-1.88-3.40-3.050.86-1.04
EPS (Weighted Average and Diluted) -1.40-4.21-3.15-1.27-0.962.591.320.34-0.091.300.50-1.88-3.40-3.050.85-1.04
Shares Outstanding (Weighted Average) 1.49M1.98M3.06M4.08M9.49M11.33M11.50M11.59M11.65M11.86M12.09M12.36M12.75M17.46M20.44M21.03M
Shares Outstanding (Diluted Average) 33.95M10.99M16.40M21.76M0.01M11.05M11.56M11.57M11.55M11.77M12.04M11.96M12.60M16.26M18.19M19.32M
EBITDA -15.94M-17.80M0.47M1.40M20.61M33.40M20.98M29.53M37.46M20.75M-11.22M-34.29M-27.88M54.47M7.98M
Interest Expenses 0.15M0.69M0.68M1.33M0.47M
Tax Rate 2.24%15.87%29.26%54.67%48.56%24.00%23.57%5.50%16.61%